Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
L-vasopressin (ID# 7820)
L-DNA
L-vasopressin/arginine vasopressin/AVP/ADH
Peptide
1.2 µM (reported value)
Buffer B: 20 mM sodium 2-[bis(2-hydroxyethyl)amino]ethane sulfonate, pH 7.3, with 140 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 1 mM CaCl2, and 0.02% Triton X-100.
RT°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Does not bind to the D-enantiomer of vassopressin and there is at least a 100-fold decrease in binding with the similar molecular oxytocin.
5'-LdTLdCLdA LdCLdGLdT LdGLdCLdA LdTLdGLdA LdTLdALdG LdALdCLdG LdGLdCLdG LdALdALdG LdCLdCLdG LdTLdCLdG LdALdGLdT LdTLdGLdC LdTLdGLdT LdGLdTLdG LdCLdCLdG LdALdTLdG LdCLdALdC LdGLdTLdG LdA-3'
55
44304.78
527800
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
K. P. Williams, D. P. Bartel, et al. Bioactive and nuclease-resistant l-DNA ligand of vasopressin. Proc. Natl. Acad. Sci., USA. 94(1997): 11285-11290.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.